Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry - Zymeworks (NASDAQ:ZYME)
GREATER VANCOUVER, BRITISH COLUMBIA, AUG 11 – Greg Ciongoli and Robert E. Landry join Zymeworks' Board to support clinical development and strategic growth during a key period with multiple regulatory approvals, CEO said.
Summary by Benzinga
6 Articles
6 Articles
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry - Zymeworks (NASDAQ:ZYME)
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced the appointments of Greg Ciongoli and Robert E. Landry to the Company's Board of Directors, effective August…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources6
Leaning Left2Leaning Right0Center2Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium